Naturade®, a leading brand in the natural products channel for more than 84 years, is proud to announce the introduction of Vitali-T-Aid™, a drug-free natural testosterone booster when used with resistance training.
When used with resistance training, Vitali-T-Aid™ is a solution for boosting free testosterone levels and increasing libido.* The natural, plant based, key ingredient in Vitali-T-Aid™ was shown in two double-blind, placebo-controlled, human clinical studies to be a safe and effective way to significantly increase free testosterone levels when used with resistance training and, as reported by study participants, improve libido. Additional findings include improved muscle mass with resistance training.*
Vitali-T-Aid was formulated to help combat the negative symptoms of androgen (testosterone) decline in the aging male, or what some people call low testosterone. Most men start experiencing a decline in both testosterone and free testosterone levels in their late 30s and these levels continue to decline by 1% – 3% per year thereafter. By age 60, 20% of men will have significantly lowered testosterone levels which may impact libido, muscle mass and other areas.
“The active ingredient in Vitali-T-Aid T-Aid™ was shown to increase free testosterone when used with resistance training. Each daily dose of Vitali-T-Aid™ also contains a proprietary Male Enhancement Blend of L-Arginine and beneficial herbs, such as Saw Palmetto, Astragalus, Tribulus and Asian Ginseng, to help support enhanced male health and well-being.* Vitali-T-Aid™ by Naturade® is a solution for increasing free testosterone levels and muscle mass with resistance training, and, as was reported by study participants, promoting healthy libido*. We are very proud to offer a science-based efficacious product that addresses a serious condition that millions of men suffer from,” said Rick Robinette, the CEO of Naturade.
Vitali-T-Aid™ is being launched with a multi-million dollar direct response television and print advertising campaign and is also available at www.vitalitaid.com
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Young adults in the early stages of developing high blood pressure (hypertension) experienced significant decreases in both systolic and diastolic blood pressures following six weeks of drinking a whey-rich beverage every day, according to findings published in the International Dairy Journal.
Effects were observed whether the subjects consumed hydrolyzed or non-hydrolyzed whey beverages, leading the researchers to propose that the benefits were due to a factor other than the presence of anti hypertensive peptides was produced during hydrolysis.
“The majority of the subjects enjoyed the taste and convenience of the functional whey protein beverages. Taste and convenience are both important to ensure compliance during a dietary intervention,” wrote researchers from Washington State University.
“Whey protein beverages may be a valuable dietary intervention in the treatment of hypertension,” they added.
High blood pressure (hypertension),defined as having a systolic and diastolic blood pressure (BP) greater than 140 and 90 mmHg, is a major risk factor for cardiovascular disease (CVD) – a disease that causes almost 50 per cent of deaths in Europe, and reported to cost the EU economy an estimated €169bn ($202bn) per year.
Led by Susan Fluegel, the WSU researchers recruited 71 young men and women with an average age of 20 and an average BMI of 24.6 kg/m2 and randomly assigned them to receive either a beverage containing 28 grams of whey protein concentrate 80 (WPC80 TemPro, Leprino Foods) or a beverage containing 28 grams of hydrolyzed WPC80. After six weeks of intervention, the researchers noted no overall differences in systolic blood pressure (SBP), diastolic blood pressure (DBP), or mean arterial pressure (MAP) between the groups. However, when Fluegel and her co-workers looked at sub-groups, they noted significant decreases of 8.0, 8.6, and 6.4 mm Hg for SBP, DBP, and MAP, respectively, in young adults with elevated DBP and SBP. The apparent benefits were observed following ingestion of either beverage. On the other hand, people with normal blood pressure levels at the start of the study had no changes in their BP measurements, they added.
“We found that whey protein beverages lowered BP only in individuals with previously high BP, but not in those with normal blood pressure,” wrote the researchers. “These findings suggest that whey protein beverages had a normalizing effect on elevated BP and did not cause hypo tension. This is important since hypo tension can be a health concern in certain population groups, such as young women and the elderly.”
Commenting on the potential mechanism, the WSU researchers noted that the effects may be related to whey’s influence on nitric oxide production – a chemical species with a known role in blood pressure regulation. Indeed, a randomized, double-blind study showed that Glanbia Nutritionals’ proprietary peptide NOP-47 improved blood vessel function in healthy individuals, with the effects occurring via nitric oxide dependent and independent mechanisms.
Source: International Dairy Journal
Volume 20, Pages 753-760, doi: 10.1016/j.idairyj.2010.06.005
“Whey beverages decrease blood pressure in prehypertensive and hypertensive young men and women”
Authors: S.M. Fluegel, T.D. Shultz, J.R. Powers, et al.
Naturade® Weight Gain Powder Recognized as a Category Leader By Consumers & Health Food Stores Nationwide. Awarded Prestigious Vity Award for 2nd Year in a Row!
ORANGE, CA - June, 2010 Naturade®, a leading brand in the natural products channel for more than 84 years, announced today that it has been awarded the prestigious Vity Award for its Weight Gain powdered drink mix for the 2nd year in a row. The annual Vity Awards honor the industry’s best-selling products based on a nationwide survey of health food stores conducted by Vitamin Retailer magazine.
“I am proud and honored that our Weight Gain Powder has once again been recognized for enhancing the lives of our loyal customers,” said Rick Robinette, the company’s CEO. “Our all natural, no sugar added formula is ideal for therapeutic use, as well as athletic weight gain & recovery. Naturade Weight Gain clearly delivers what our consumers are looking for in a high quality weight gain product.”
Naturade® is a leading supplier of high quality, science-based nutritional supplements and functional food products to the Natural Products channel, the Food, Drug, Mass, Club trade channels, as well as the Professional channel. Naturade® has been providing high quality nutritional supplements since 1926. The company markets a number of products under the brands Naturade®, Symbiotics®, ProSymbiotics® and Ageless Foundation Laboratories®.
A new study finds that the isoflavone in soybeans can prevent a second stroke in individuals suffering from cerebrovascular events. According to the study published in The European Heart Journal, isoflavone reverses endothelial dysfunction in stroke sufferers.
Similar to cholesterol-lowering drugs, the chemical, also known as a phytoestrogen due to its estrogen-like effects, can improve the arterial blood flow in patients with a positive stroke history. Previous studies had reported that soy-rich diets can lower blood cholesterol levels and help prevent breast and prostate cancers. Isoflavones are also effective in lowering the risk of arteriosclerosis and other cardiovascular events.
University of Hong Kong scientists concluded that taking isoflavone dietary supplements can help reduce the risk of future strokes or cardiovascular events in stroke patients.
Bovine colostrum supplemented orally is known to support healthy human immunity. Healthy men cycled for 2 hours after receiving a daily colostrum for 4 weeks (in comparison to a control group) as done in a new study. There were no deficits in the front line immunity of those taking the colostrum, in contrast to those experienced by the group not taking colostrum.
Aerobic exercise may be good for overall health but it can weaken the immune system
Obtaining a decent response to aerobic exercise is vital for longevity and health. However, one problem is that exercise can diminish the front line of your immune system. This will be certainly relevant to those actively exercising during the winter bug season. This study reveals that daily ingesting colostrum can prevent a lowering of your immune system function.
Although this study was performed on healthy men, its value could be particularly important to individuals struggling with exercise, like those with fibromyalgia. In this scenario, exercise is crucial for improvement but performing exercise can be a problem and create a whole set of problems. It is probable that colostrum, which is a far-reaching powerhouse metabolically, would appear to be useful to aid in the response to exercise in such individuals.
Colostrum is formulated to support the requirements of the high growth phase in infants, a nutrient suited ideally for enhanced recovery and regeneration that goes with the process of fast growth. It appears that it fits in well as a support nutrient for rehabilitation from excess demands linked with physical performance. In this case it is proven in healthy men, but theoretically also aiding those who fight to get a good response to exercise (which is consonant with observations of the nutrient in clinical practice.)
Literature Review Finds No Indication that Soy Decreases Testosterone Levels
ST LOUIS, July 20 /PRNewswire/ — A new study published by the American Society for Reproductive Medicine finds that soyfoods and soy isoflavone supplements have no significant effect on male reproductive hormone levels in men. The literature review indicates that soy does not decrease testosterone levels.
Led by Jill M. Hamilton-Reeves, PhD, RD, of St. Catherine’s University, St. Paul, Minnesota, researchers assessed the effects of soy protein and soy isoflavones on measurements of male reproductive hormones. Findings, just published online in Fertility and Sterility, a publication of the American Society for Reproductive Medicine, demonstrate no significant effect of soy protein or soy isoflavone intake on circulating levels of testosterone, sex hormone-binding globulin or free testosterone in men.
The comprehensive meta-analysis examined the existing scientific literature including all clinical studies examining soy’s effect on male reproductive hormones published before July 1, 2008. Fifteen placebo-controlled treatment groups with baseline and ending measures were analyzed. Thirty-two reports involving 36 treatment groups were also assessed in simpler statistical models. Studies published after July 1, 2008, which were not included in the meta-analysis, support the conclusions of the meta-analysis.
Reproductive endocrinologist William R. Phipps, MD, of the University of Rochester Medical Center, a co-author of the analysis stated, “As a high-quality source of protein that is relatively low in saturated fat, soy can be an important part of a heart-healthy diet and may contribute to a decreased risk of coronary heart disease.” He noted that some men have been reluctant to consume soyfoods due to concerns about estrogen-like effects of soy isoflavones, often referred to as phytoestrogens. But according to Phipps, “it is important for the public to understand that there is no clinical evidence to support these ideas. After conducting a comprehensive review of the existing literature, we found no indication that soy significantly alters male sex hormone levels.”
Men can benefit from soyfood consumption as a means to meet daily protein requirements and at the same time possibly also reducing their risk of heart disease.
Citing the research study, Lisa Kelly, MPH, RD, of the United Soybean Board, added,
“Soy is often praised for the positive role it can play in the diets of women. But, years of clinical research have shown that men stand to benefit from soy, too. I encourage men to incorporate soyfoods into a balanced and varied diet and talk to their healthcare provider about their own unique nutritional needs.”
SOURCE: United Soybean Board
ScienceDaily (Mar. 17, 2008) â€” A compound found in soybeans almost completely prevented the spread of human prostate cancer in mice, according to a study published in the March 15 issue of Cancer Research, a journal of the American Association for Cancer Research.
Researchers say that the amount of the chemical, an antioxidant known as genistein, used in the experiments was no higher than what a human would eat in a soybean-rich diet.
Investigators from Northwestern University found that genistein decreased metastasis of prostate cancer to the lungs by 96 percent compared with mice that did not eat the compound in their chowÂ â€” making the study the first to demonstrate genistein can stop prostate cancer metastasis in a living organism.
â€œThese impressive results give us hope that genistein might show some effect in preventing the spread of prostate cancer in patients,â€ said the studyâ€™s senior investigator, Raymond C. Bergan, MD, director of experimental therapeutics for the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
â€œDiet can affect cancer and it doesnâ€™t do it by magic,â€ Bergan said. â€œCertain chemicals have beneficial effects and now we have all the preclinical studies we need to suggest genistein might be a very promising chemopreventive drug.â€
Bergan and his team have previously demonstrated in prostate cancer cell cultures that genistein inhibits detachment of cancer cells from a primary prostate tumor and represses cell invasion. It does this by blocking activation of p38 MAP kinases, molecules which regulate pathways that activate proteins that loosen cancer cells from their tight hold within a tumor, pushing them to migrate. â€œIn culture, you can actually see that when genistein is introduced, cells flatten themselves in order to spread out and stick strongly to nearby cells,â€ he said.
In this study, investigators fed genistein to several groups of mice before implanting them with an aggressive form of prostate cancer. The amount of genistein in the blood of the animals was comparable to human blood concentrations after consumption of soy foods, Bergan said.
The researchers found that while genistein didnâ€™t reduce the size of tumors that developed within the prostate, it stopped lung metastasis almost completely. They repeated the experiment and found the same result.
They then examined tissue in the animals, measuring the size of tumor cellsâ€™ nuclei to determine if the cells had flattened out in order to spread. â€œWithin a tumor, it is hard to tell where the borders of cells stop, so one way to measure adherence is to look at the size of the nuclei in cells and see if they are wider due to cell spread,â€ Bergan said. â€œAnd that is what we found, demonstrating that the drug is having a primary effect on metastasis.â€
He said that the study also found that mice fed genistein expressed higher levels of genes that are involved in cancer cell migration which, Bergan says, at first might not make sense in light of the studyâ€™s conclusion that genistein almost completely blocked metastasis.
â€œWhat we think is happening here is that the cells we put in the mice normally like to move. When genistein restricted their ability to do so, they tried to compensate by producing more protein involved in migration. But genistein prevented those proteins from being activated,â€ he said. â€œThis is really a lesson for researchers who depend on biomarker studies to test whether a treatment is working. They need to be aware that those biomarkers might be telling only half of the story.â€
Bergan cautioned that much is unknown about use of genistein in preventing cancer spread. For example, it may be that the effects of the compound in people who have eaten soy all their lives is stronger than benefit seen in patients who have only started to use genistein.
â€œThe problem we have faced is that epidemiology studies that found men who eat soy are at reduced risk of prostate cancer death are all associative. They donâ€™t prove anything,â€ he said. â€œThe only way we will find out how promising genistein is will be from conducting clinical trials.â€